scholarly journals Evaluation of Hyperosmotic Sodium Bicarbonate as Adjunct to Ciprofloxacin in the Amelioration of Septicaemia in Salmonella-Induced Bubaline Neonatal Diarrhoea

2021 ◽  
Vol 25 (05) ◽  
pp. 921-928
Author(s):  
Ayesha Humayun
Keyword(s):  
Sodium Bicarbonate ◽  
Partial Pressure ◽  
Blood Gases ◽  
Comparative Efficacy ◽  
Treatment Regimens ◽  
Flunixin Meglumine ◽  
Neonatal Diarrhoea ◽  
Group A ◽  
Neonatal Calves ◽  
Group B

This study was conducted to evaluate the comparative efficacy of hyperosmotic sodium bicarbonate (HSB 8.4%), hypertonic saline (HSS 7.5%) and normal saline (NSS 0.9%) solutions associated with experimentally Salmonella-induced diarrhoea in buffalo neonatal calves. For this purpose, 14–17 days old 18 healthy buffalo calves were reared. After 8–12 h of oral administration of Salmonella broth (6.5 × 108 CFU), diarrhoea was induced successfully. Calves were then randomly divided into three equal groups viz., groups A, B and C and treatment was instituted. Group A received NSS (0.9%) @ 60 mL/kg (body weight) B.W, intravenous (IV) once, group B was administered HSS (7.5%) @ 5 mL/kg B.W, IV once and group C instituted with HSB (8.4%) @ 5 mL/kg B.W, IV once. All three groups were additionally treated with ciprofloxacin @ 7 mg/kg B.W, IV bid and flunixin meglumine @ 2 mg/kg B.W, IV tid. Comparative efficacy of all treatment regimens was assessed through haemodynamic measurements, blood gases determination and serum electrolyte analysis. All parameters were noted at baseline (prior to diarrhoea induction), during neonatal diarrhoea, t=3, t=9, t=18, t=36, t=72, t=120, t=168 h after treatment. The HSB treated calves (group C) revived from diarrhoea quickly (within 9 h) and efficiently than NSS (group A) and HSS (group B), exhibited significantly (P < 0.05) enhancement. At t=18 h, values for central venous partial pressure and systemic vascular resistance were 11.67 ± 0.7, 13.67 ± 0.61 and 13.50 ± 0.56 and 1180. 83 ± 6.94, 1180.83 ± 6.94 and 1465.00 ± 6.76 in groups A, B and C, respectively. HSB treated buffalo neonatal calves also showed significant increase in bicarbonate, blood pH, serum electrolytes and partial pressure of venous oxygen. Basis on the results of this study, it was concluded that small-volume administration of HSB profoundly ameliorated deleterious effects of septicaemia and improve haemodynamic stability in Salmonella-induced bubaline neonatal diarrhoea. It provides a practical and economical method to resuscitate dehydrated diarrhoeic calves thus make it convenient to accomplish in on-farm situation. © 2021 Friends Science Publishers

Moxifloxacin Based Triple Therapy as Alternative to Standard Therapy in Helicobacter Pylori Eradication.

2020 ◽  
Vol 18 ◽  
Author(s):  
Mohammed Hussien Ahmed ◽  
Sherief Abd-Elsalam ◽  
Aya Mohammed Mahrous
Keyword(s):  
Helicobacter Pylori ◽  
Triple Therapy ◽  
Therapy Group ◽  
Low Cost ◽  
High Rate ◽  
Helicobacter Pylori Eradication ◽  
Treatment Regimens ◽  
Group A ◽  
H Pylori ◽  
Group B

Introduction: Helicobacter pylori eradication remains a problematic issue. We are in an urgent need for finding a treatment regimen that achieves eradication at a low cost and less side effect. Recent published results showing a high rate of resistance and with clarithromycin-based treatment regimens. The aim of the study was to compare moxifloxacin therapy and classic clarithromycin triple therapy in H. pylori eradication. Methods: This was a pilot study that enrolled 60 patients with helicobacter pylori associated gastritis. Diagnosis was done by assessment of H. pylori Ag in the stool. The patients were randomly assigned to receive either moxifloxacin based therapy (Group A), or clarithromycin based therapy (Group B) for two weeks. We stopped the treatment for another two weeks then reevaluation for cure was done. Results: 90 % of patients had negative H. pylori Ag in the stool after 2 weeks of stoppage of the treatment in group A versus 66.7 % in Group B. None of the patients in both groups had major side effects. Conclusion: Moxifloxacin-based therapy showed higher eradication power and less resistance when compared to clarithromycin triple therapy.

Evaluation of comparative efficacy of Guda Sunthi and Manjistha Guggulu Avapeedana Nasya in Manyastambha (Cervical Spondylitis)

2019 ◽  
Vol 4 (02) ◽  
Author(s):  
Manjunath Akki ◽  
Suresh Hakkandi ◽  
Arti Panwar
Keyword(s):  
Complete Remission ◽  
Routine Activities ◽  
Household Work ◽  
Comparative Efficacy ◽  
Exclusion Criteria ◽  
Patient Complaints ◽  
The People ◽  
Comparative Clinical Study ◽  
Group A ◽  
Group B

Manyastambha is described under Nanatmaja Vatavyadhi. It is a condition where, the aggravated Vata get localized in the Manya Pradesha causing symptoms like Stambha and Shoola. Manyastambha can be compared with earliest symptoms of cervical spondylitis. In this condition, patient complaints of neck pain. The neck is held rigidly and neck movements may exacerbate pain. Now a day, Cervical spondylitis is very common in the people who do routine activities like travelling, household work, desk job etc. It can be seen in people as early as 25 years of age. In Manyastambha, Nasya is the main line of treatment. (i.e. Vatakaphahara Nasya). Objectives: To evaluate the comparative efficacy of Guda Sunthi Avapeedana Nasya and Manjistha Guggulu Avpeedana Nasya in Manyastambha (Cervical Spondylitis). Materials and Methods: This is a comparative clinical study conducted to assess the efficacy in Manyastambha. As per the inclusion and exclusion criteria, the patients who fulfill the criteria were randomly selected and equally divided into two groups. Group A - 15 Patients received Guda-Sunthi Avapeedana Nasya. Group B - 15 Patients received Manjistha-Guggulu Avapeedana Nasya. Results and Conclusion: In Group A, 9 patients (60%) showed complete remission and 6 patients (30%) showed marked response. In Group B, 3 patients (20%) showed complete remission, 1 patient (7%) showed marked response. 6 patients (30%) showed moderate response, 4 patients (26%) showed mild response and 1 patient (7%) showed unchanged response.

scholarly journals Role of enteric pathogens in the aetiology of neonatal diarrhoea in lambs and goat kids in Spain

1996 ◽  
Vol 117 (1) ◽  
pp. 203-211 ◽  
Author(s):  
M. Muñoz ◽  
M. Álvarez ◽  
I. Lanza ◽  
P. Cármenes
Keyword(s):  
Escherichia Coli ◽  
Synergistic Effect ◽  
Cryptosporidium Parvum ◽  
Clinical Characteristics ◽  
Enteric Pathogens ◽  
E Coli ◽  
Neonatal Diarrhoea ◽  
Group A ◽  
Group B

SummaryFaeces samples from diarrhoeic and non-diarrhoeic lambs and goat kids aged 1–45 days were examined for enteric pathogens.Cryptosporidium parvumwas detected in both diarrhoeic lambs (45%) and goat kids (42%) but not in non-diarrhoeic animals. F5+(K99+) and/or F41+Escherichia colistrains were isolated from 26% and 22% of the diarrhoeic lambs and goat kids, respectively, although these strains, which did not produce enterotoxins ST I or LT I, were found with similar frequencies in non-diarrhoeic animals. A F5−F41−ST I+E. colistrain was isolated from a diarrhoeic lamb (0·6%). VerotoxigenicE. coliwas isolated from both diarrhoeic and non-diarrhoeic lambs (4·1% and 8·2%, respectively) and there was no association between infection and diarrhoea. The prevalence of group A rotavirus infection in diarrhoeic lambs was very low (2·1%). Groups A and B rotaviruses were detected in three (8·1%) and five (13·5%) diarrhoeic goat kids from two single outbreaks. Group C rotaviruses were detected in four non-diarrhoeic goat kids. An association of diarrhoea and infection was demonstrated only for group B rotavirus.Clostridium perfringenswas isolated from 10·8% of the diarrhoeic goat kids but not from non-diarrhoeic goat kids or lambs.Salmonella arizonaewas isolated from a diarrhoeic goat kid (2·7%) and the clinical characteristics of the outbreaks where these two latter enteropathogens were found different from the rest. Picobirnaviruses were detected in a diarrhoeic lamb. No coronaviruses were detected using a bovine coronavirus ELISA. No evidence was found of synergistic effect between the agents studied. Enteric pathogens were not found in four (8·7%) and three (20%) outbreaks of diarrhoea in lambs and goat kids, respectively.

scholarly journals Abdominal Wound Closure in Gynaecological or Obstetrical Surgery with Vicryl® (Polyglactin910) Versus Vicryl Plus® (Polyglactin910 with Triclosan Added): A Comparative Study

2019 ◽  
Vol 17 (1) ◽  
pp. 10-12
Author(s):  
Binod Kumar Mahaseth
Keyword(s):  
Surgical Site Infection ◽  
Surgical Complication ◽  
College Teaching ◽  
Controlled Study ◽  
Skin Closure ◽  
Site Infection ◽  
Comparative Efficacy ◽  
Group A ◽  
Group B ◽  
Johnson Company

Background: Surgical site infection is the most common post-surgical complication in surgical patients. The incidence of surgical site infection varies from 3-20% (or even more) in different part of the world. To date, the best method and material for skin closure has not been recommended by anybody. Triclosan is an antiseptic agent used for coating a suture material to prevent the infections. This case-controlled study was carried out to determine the comparative efficacy of sutures; Objective: This case-controlled study was carried out to determine the comparative efficacy of sutures: vicryl® and vicryl plus® (triclosan, an antiseptic incorporated with suture), in reducing surgical site infection in laparotomy for clean Gyn/Obs operations. Material and method: This case-controlled study was carried out in Dept. Of Gynae/Obs at Nepalgunj Medical College Teaching Hospital, Kohalpur. The period of the study was from Jan 2018 to January 2019. A total of 50 participants were enrolled in the study, who met the inclusion criteria. The patients were divided into two groups A and B, each consisting of 25 patients. The patients were allocated in the groups alternately to remove bias. The Group A consisted of patients where Vicrylplus® (Ethicon, Johnson & Johnson Company, Ahmadabad, India) polyglactin910 with triclosan) was used and Group B consisted of patients where vicryl ® (Ethicon, Johnson & Johnson Company, Ahmadabad, India) polyglactin910 alone) was used. Patients whose abdominal wounds were found infected, pus swab for culture were taken and sent for aerobic culture and sensitivity. All patients received ceftriaxone and metronidazole single dose before operations prophylactically. Result: Surgical site infection ingroup A was 3 cases out of 25 (12%) and in group B it was 6 cases out of 25(24%). Triclosan added polyglactin910 suture found to be statistically non significant concerning prevention of SSI as compared to polyglactin910 (p=0.472). The mean age of the study population was in group A was (29.76±7.47) and in group B was (27.12±7.42).

Does size matter concerning impact of position on oxygenation status in spontaneously breathing patients with unilateral effusion?

2017 ◽  
Vol 94 (1108) ◽  
pp. 81-86 ◽  
Author(s):  
Stylianos A Michaelides ◽  
Avgerinos-Romanos Michailidis ◽  
George D Bablekos ◽  
Antonis Analitis ◽  
Maria Michalatou ◽  
...  
Keyword(s):  
Pleural Effusion ◽  
Body Position ◽  
Blood Gases ◽  
Costal Margin ◽  
Arterial Blood ◽  
Group A ◽  
Group B ◽  
Spontaneously Breathing ◽  
Size Matter ◽  
The Impact

BackgroundInconsistent and contradictory findings have appeared in the literature concerning the impact of body position on oxygenation in pleural effusion.MethodsWe attempted to elucidate whether the size of the pleural effusion in patients with no parenchymal disease is the main determinant of posture-induced alterations in oxygenation parameters. We studied 62 spontaneously breathing patients aged 65.3±7.8 years (mean±SD), of whom 36 had large and massive-sized effusions (Group A) and 26 had small and moderate-sized effusions (Group B). Arterial blood gases were determined in four different body positions: sitting (SIT), supine (SUP), ipsilateral (IPS) and contralateral (CON) to the effusion side, after remaining relaxed for at least 20 min in each position. Separation into groups A and B was deliberately set from the position of the fluid meniscus line on a posteroanterior chest film just above the upper costal margin of the sixth anterior rib. A two-way ANOVA model with outcome variables PaO2, PaCO2 and [A–a] DO2 was used.ResultsIn both groups the best oxygenation was found in SIT. The worst oxygenation (highest [A–a] DO2 value) occurred in group A in CON compared with IPS (59.4±7.6 vs 49.0±7.5 mm Hg, p<0.001) and in group B in IPS compared with CON (51.0±8.7 vs 39.5±9.2 mm Hg, p<0.001). Also, PaCO2 showed significant differences in both groups in IPS compared with CON (p=0.002).ConclusionsPatients with large-sized effusions exhibit the worst oxygenation when lying on the side contralateral to the effusion, while those with small-sized effusions exhibit the worst oxygenation when lying on the side ipsilateral to the effusion.

scholarly journals Comparative Efficacy of Low level Laser Therapy And Pulsed Ultrasound in the Management of Second - Degree Contusion

2007 ◽  
Author(s):  
O Ayanniyi ◽  
O B Ogunkunle ◽  
C E Mbada
Keyword(s):  
Laser Therapy ◽  
Low Level Laser Therapy ◽  
Comparative Efficacy ◽  
Pulsed Ultrasound ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser ◽  
Group A ◽  
Group B ◽  
Second Degree

Low level LASER therapy (LLLT) and pulsed ultrasound have been shown to relieve pain, promote healing and tissue repair in sport injuries. The objective of this study was to investigate the comparative efficacy of LLLT and pulsed ultrasound in the management of second - degree contusion in sportsmen. This is a 2 group pre-test – post-test quasi – experimental study involving 20 sportsmen, ten were in Group A (LLLT) and ten in Group B (P-US). They were aged between 19 and 30 years with the mean age 24.9 ± 3.28 years and 27.4 ± 3.75 years for the Group A and Group B respectively. Treatment consisted of six sessions, in a period of 2 weeks. Data collected on each participants included age, weight, height, site of injury, pain intensity, swelling, calf girth and range of motion. The result of the study revealed decrease in pain for both LLLT and pulsed ultrasound (p0.05). It was concluded that both therapies are equally effective in the management of pain resulting from second – degree contusion in sportsmen. KEYWORDS: Low level LASER, pulsed ultrasound, second – degree contusions.

Value of endobronchial cryotherapy in the management of malignant endobronchial obstruction in patients with inoperable NSCLC: A prospective analysis of clinical and survival outcomes

2020 ◽  
Author(s):  
Alaa Rashad ◽  
Mohamed Shahat Badawy ◽  
Mohammed Mustafa Ali ◽  
Haggagy Mansour ◽  
Mohamed Abdel Bary
Keyword(s):  
Median Survival ◽  
Performance Status ◽  
Blood Gases ◽  
University Hospital ◽  
Survival Outcomes ◽  
Safe Procedure ◽  
Karnofsky Score ◽  
Arterial Blood ◽  
Group A ◽  
Group B

Abstract Background: Malignant endobronchial obstruction (MEBO) is the most debilitating complication in non-small cell lung cancer (NSCLC). The therapeutic role of cryotherapy and its impact on survival has not been well addressed. This is to clarify whether the combination of endobronchial cryotherapy (EBCT) and chemoradiotherapy (CRT) improved the outcomes in inoperable NSCLC patients with symptomatic MEBO compared to that obtained by CRT alone.Methods: A prospective ranomized cohort study included 60 cases presented to Qena University Hospital, Egypt, between December 2016 and May 2019. Group A included 30 patients were managed with EBCT plus CRT. Group B included 30 patients were managed with CRT alone. The outcomes assessed were symptoms relief, respiratory function tests (RFT), performance status and survival outcomes at baseline and 4 weeks of follow-up.Results: Group A patients showed a highly significant improvement in symptoms, RFT, 6MWD test and arterial blood gases, compared to group B. The mean Karnofsky score increased from 57.33±5.67 % at baseline to 60.67±6.39 % post-EBCT (P=0.036); group A was significantly improved compared to group B (P=0.04). The Kaplan-Meier median survival for all patients was 9.7±0.4 months (95% CI= 8.86-10.54), and group A cases (10.77±0.44 months, 95% CI= 9.9 -11.6) was significantly longer than that of group B cases (8.6±0.68 months, 95% CI= 7.3-9.97; T-test = 2.631, P= 0.011). Conclusion: The use of EBCT with CRT for the management of MEBO in symptomatic patients with inoperable NSCLC is an efficient and safe procedure. EBCT improves the clinical outcomes, RFT, performance status and median survival.

Comparative Study of the Efficacy of Biofeedback-Assisted Jacobsons Progressive Muscle Relaxation (Jpmr) for Managingmild/Moderate Depression

2021 ◽  
Author(s):  
Swayamprava prava baral ◽  
Gyanendra Raghuvanshi ◽  
Abhay paliwal
Keyword(s):  
Muscle Relaxation ◽  
Self Regulation ◽  
Progressive Muscle Relaxation ◽  
Adjunctive Treatment ◽  
Muscular System ◽  
Comparative Efficacy ◽  
Moderate Depression ◽  
Scale Scores ◽  
Group A ◽  
Group B

Abstract Biofeedback is the way of gaining greater awareness of physiological functions with a goal of self-regulation. JPMR (Jacobsons progressive muscle relaxation) causes release of tension in the skeletal muscles, neuro-muscular system is thus seen as a mediator in the relief of depressive symptoms. This study aimed to see the Comparative efficacy of Biofeedback assisted JPMR, Escitalopram and Bimodal use of both in management in mild/moderate depression. The study was conducted at Mental hospital, Indore, with a Sample Size of 30 [Group A 10 ; biofeedback ,Group B 10 ; Escitalopram ,Group C 10;both]. 8 sessions of biofeedback assisted JPMR was given to group A and C .Escitalopram was given group B and C. HAM-D and BDI was applied at baseline , 4 weeks and 8 weeks. As per BDI scale scores, Biofeedback assisted JPMR combined with escitalopram has significantly better response than only biofeedback or only Escitalopram in patients of mild to moderate depression. As per HAM-D scale scores, Biofeedback assisted JPMR combined with escitalopram has significantly better response than only biofeedback or only Escitalopram in patients of mild to moderate depression. Thus Biofeedback appears to be a useful adjunctive treatment for mild to moderate depressive episode.

scholarly journals Comparative efficacy of avinew (VG/GA strain) and BCRDV (F strain) vaccines against Newcastle disease in broiler chickens

1970 ◽  
pp. 19-23
Author(s):  
MS Mahmud ◽  
MT Hossain ◽  
P Monoura ◽  
MM Amin
Keyword(s):  
Newcastle Disease ◽  
Challenge Test ◽  
Maternal Antibody ◽  
Case Group ◽  
Broiler Chicks ◽  
Comparative Efficacy ◽  
Unvaccinated Control ◽  
Group A ◽  
Group B ◽  
Sera Samples

A study was conducted for the detection of persistence of maternal antibody as well as the comparative efficacy of Avinew (VG/GA Strain) and BCRDV (F Strain) vaccines against Newcastle disease during the period from January to April 2006 using 100 day-old broiler chicks divided into three groups namely A, B and C. Birds of groups A and B consisting each of 40 were primarily vaccinated intraocularly (IO) with Avinew and BCRDV respectively at the age of day three (3) and secondarily with the same vaccines, as the cases were, on day 20. Sera samples were obtained from 10 randomly selected birds on each occasion of day 1, 10, 17, 27, 30, 34 and 44 of age of birds. Birds of group C were maintained as unvaccinated control for the determination of existence of maternal antibody parallel to the day of vaccination and challenge. It was observed that following primary vaccination in case of group A, the HI titres with a mean ± SD on day 10 and 17 were 121.6 ± 19.2 and 60.8 ± 9.60 respectively as against at mean titres ± SD of 57.6 ± 12.8 and 30.4 ± 4.80 in case group B respectively. On the other hand, subsequent to secondary vaccination, sera samples obtained from group A on day 27 had a mean ± SD of HI titres 128 ± 0 and in case of group B, the performance of Avinew in respect of such titre was 57.6 ± 12.8 on day 27. Thus it was indicated that performance of Aninew in respect of elucidation of HI antibody was comparatively better than that of BCRDV. In case of unvaccinated control birds of group C, the mean of existence of maternal antibody with ± SD were 512 ± 0, 54.4 ± 14.66, 24 ± 8, 12.8 ± 8.54, ≤ 4, ≤ 4 and ≤ 4 at the age of day 1, 10, 17, 27, 30, 34 and 44 respectively. One half of vaccinated birds of groups A and B were subjected to challenge test with a virulent isolate of NDV on each of two occasion of day 30 and 44 of age of birds where it was observed that 100% of both the groups of A and B were refractory to each test whereas 95% and 85% of the remaining half of birds of groups A and B resisted the challenge exposure. It was found that maternal antibody against NDV in chicks persisted to a minimal until the age of day 27 and none at day 30 or 34. The analysis of HI titres by Student's t-test revealed that Avinew vaccinated group maintained significantly higher HI titres following primary and secondary vaccination as well as during first challenge than that of BCRDV vaccinated group. Key words: Avinew, BCRDV, efficacy, vaccine, broiler chicks   DOI = 10.3329/bjvm.v5i1.1304 Bangl. J. Vet. Med. (2007). 5 (1 & 2): 19-23

scholarly journals Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

2019 ◽  
Vol 12 ◽  
pp. 175628481987096
Author(s):  
Chia-Jung Kuo ◽  
Chun-Wei Chen ◽  
Puo-Hsien Le ◽  
Jun-Te Hsu ◽  
Cheng-Yu Lin ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Triple Therapy ◽  
Breath Test ◽  
Eradication Rate ◽  
Urea Breath Test ◽  
Helicobacter Pylori Eradication ◽  
Treatment Regimens ◽  
Group A ◽  
H Pylori ◽  
Group B

Background: Dexlansoprazole has been shown to be efficacious for the treatment of gastroesophageal reflux disease. However, there is a paucity of data about its efficacy for Helicobacter pylori eradication. The aim of this study was to evaluate the efficacy of dexlansoprazole for H. pylori eradication as triple therapy in real-world practice. Methods: Adult patients with endoscopically proven H. pylori related peptic ulcer diseases or gastritis were recruited for this study. The eradication status was assessed based on the results of the 13C-urea breath test performed 4 weeks after treatment. According to the different treatment regimens, the patients were allocated to group A: Esomeprazole 40 mg b.i.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 days; group B: Esomeprazole 40 mg q.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 days, or group C: Dexlansoprazole 60 mg q.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 days. Results: A total of 215 patients (49% males) were enrolled in this study, with a mean age of 55 years. The eradication rates in group A, B, and C were 94.7% (71/75), 89.6% (69/77), and 93.7% (59/63) ( p = 0.457), respectively. The adverse events were similar between the three groups ( p = 0.068). Conclusions: This study suggests that dexlansoprazole-based triple therapy has an acceptable eradication rate for H. pylori infection.

Sign in / Sign up

Export Citation Format

Share Document